Efficacy of piperacillin/tazobactam as initial empiric therapy of febrile neutropenia in patients with hematologic malignancy.

被引：0
|
作者：
Bow, EJ
Noskin, GA
Schwarer, AP
Laverdiere, M
Vesole, DH
机构：
[1] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada
[2] Northwestern Univ, Sch Med, Chicago, IL USA
[3] Alfred Hosp, Melbourne, Vic, Australia
[4] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1000
引用
收藏
页码：281A / 281A
页数：1
相关论文
共 50 条
  • [21] Piperacillin/tazobactam vs. piperacillin/tazobactam plus amikacin as empiric therapy for fever in neutropenic patients.
    Esteve, J
    Nomdedeu, B
    Mensa, J
    Guardia, R
    Marco, F
    Montserrat, E
    BLOOD, 1997, 90 (10) : 3767 - 3767
  • [22] A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia
    Aynioglu, Aynur
    Mutlu, Birsen
    Hacihanefioglu, Abdullah
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 (02) : 69 - 75
  • [23] Efficacy of Piperacillin/Tazobactam and Meropenem used as Second-Line Therapy with or without Intravenous Immunoglobulin Administration for Febrile Neutropenia
    Sano, Hirozumi
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Kodama, Koya
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [24] Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients (vol 49, pg 26, 2008)
    Hamidah, A.
    Rizall, A. M.
    Nordiah, A. J.
    Jamal, R.
    SINGAPORE MEDICAL JOURNAL, 2008, 49 (02) : 179 - 179
  • [25] A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia
    Del Favero, A
    Menichetti, F
    Martino, P
    Bucaneve, G
    Micozzi, A
    Gentile, G
    Furno, P
    Russo, D
    D'Antonio, D
    Ricci, P
    Martino, B
    Mandelli, F
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1295 - 1301
  • [26] Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: A randomized comparison
    Corapcioglu, F
    Sarper, N
    Zengin, E
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (03) : 177 - 186
  • [27] Efficacy of Piperacillin Tazobactum as Empiric Treatment of Febrile Neutropenia in Children and Young Adults on Cancer Chemotherapy
    Borker, A.
    Subramanian, P.
    Chichra, A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S500 - S500
  • [28] Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients
    Kobayashi, Ryoji
    Hori, Daiki
    Sano, Hirozumi
    Suzuki, Daisuke
    Kishimoto, Kenji
    Kobayashi, Kunihiko
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (04) : 473 - 477
  • [29] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    José C Álvarez
    Sonia I Cuervo
    Javier R Garzón
    Julio C Gómez
    Jorge Augusto Díaz
    Edelberto Silva
    Ricardo Sánchez
    Jorge A Cortés
    BMC Pharmacology and Toxicology, 14
  • [30] EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA - RESPONSE
    DEPAUW, BE
    DONNELLY, JP
    ANNALS OF INTERNAL MEDICINE, 1994, 121 (08) : 623 - 624
12345